Abstract:
New original derivatives are described of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4-oxobutanoic acids having the formula: ##STR1## in which n is 1 or 2, R.sub.1 is selected from the groups 2-naphthyl, 2 (or 3)-quinolinyl, 2 (or 3)-indolyl, 2 (or 3)-benzofuranyl, 2 (or 3)-benzothiophenyl, and R.sub.2 is a pentyl group or an alkoxyalkyl group with 4 or 5 carbon atoms, preferably pentyl, 2-ethoxyethyl, 3-methoxypropyl or 3-ethoxypropyl.The compounds have a powerful antagonistic activity towards cholecystokinin and are particularly useful in the treatment of illnesses of the digestive system, such as colitis, biliary diskinesia, pancreatitis or in the treatment of disorders of the central nervous system imputable to deficiencies in the physiological neuron levels of cholecystokinin or other related bioactive polypeptides.
Abstract:
The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.
Abstract:
New original derivatives are described of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4-oxobutasnoic acids having the formula: ##STR1## in which n is 1 or 2, R.sub.1 is selected from the groups 2-naphthyl, 2 (or 3)-quinolinyl, 2 (or 3)-indolyl, 2 (or 3)-benzofuranyl, 2 (or 3)-benzothiophenyl, and R.sub.2 is a pentyl group or an alkoxyalkyl group with 4 or 5 carbon atoms, preferably pentyl, 2-ethoxyethyl, 3-methoxypropyl or 3-ethoxypropyl.The compounds have a powerful antagonistic activity towards cholecystokinin and are particularly useful in the treatment of illnesses of the digestive system, such as colitis, biliary diskinesia, pancreatitis or in the treatment of disorders of the central nervous system imputable to deficiencies in the physiological neuron levels of cholecystokinin or other related bioactive polypeptides.
Abstract:
Novel 1-heterocyclyloxy-or 1-aryloxy-3-amidoalkylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess .beta.-adrenergic blocking activity. Representative of the compounds disclosed is 1-(4-indolyloxy)-3-.beta.-isobutyramidoethylamino-2-propanol.
Abstract:
A broad class of furan-3-Carboxamide derivatives, including many novel compounds, can be made reliably and in good yields by a novel one step reaction between an .alpha.-hydroxyketone and an acetamide in the presence of a Friedel-Crafts agent in an inert solvent. The broad class of derivatives has fungicidal and insecticidal utility.
Abstract:
Derivatives of 5-oxy-6-aminomethylbenzofuran having the general formula ##SPC1##Where R is alkyl, R' is alkyl, aryl, R.sup.2 is alkyl, R.sup.3 is alkyl, or R.sup.2 and R.sup.3, together with a nitrogen atom to which they are bonded, form a heterocycle comprising one or two hetero-atoms, and X is a halogen.Said compounds are prepared by aminomethylation of derivatives of 5-oxybenzofuran having the formula ##SPC2##Where R is alkyl, R' is alkyl, aryl, and X is a halogen.The reaction of aminomethylation can be carried out with a substituted bisaminomethane or with a mixture, consisting of a secondary amine and formaldehyde.Said compounds possess pharmacological activity.
Abstract:
Benzofuran compounds of the general formula:
AND THE PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, WHEREIN R represents a branched- or straight-chain alkyl group containing from 1 to 4 carbon atoms or a cyclohexyl radical; R1 and R2, which are identical, each represent a hydrogen atom or a straight-chain alkyl group containing from 1 to 3 carbon atoms; Am represents a dimethylamino, diethylamino, di-n-propylamino, di-n-butylamino, piperidino, N-methyl-piperazino, N-ethylpiperazino, N-n-propyl-piperazino, N-phenyl-piperazino, methyl-nbutylamino, ethyl-n-butylamino, methylamino, ethylamino, npropylamino, isopropylamino or n-butylamino group and n is an integer in the range of from 3 to 6 inclusive.
Abstract:
Described herein are phenylsulfonamido-benzofuran derivatives, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions, methods, uses, and kits involving compounds of Formulae (I), (II), (III), (IV), (V), or (VI) for treating and/or preventing proliferative diseases (e.g. cancers, inflammatory diseases, and autoimmune diseases) in a subject. The compounds and pharmaceutical compositions as described herein inhibit at least one protein of the BCL-2 family in a biological sample or subject to treat and/or prevent a proliferative disease. In certain embodiments, compounds described herein are selective inhibitors of MCL-1, a BCL-2 family member protein.